These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6372240)

  • 1. [Treatment of arterial hypertension patients depending on renin activity].
    Naugol'nova SB; Lapshina LA
    Vrach Delo; 1984 Feb; (2):61-5. PubMed ID: 6372240
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of various hypotensive drugs on the plasma level of kininogen and prekallikrein in hypertension].
    Kolber-Postepska B; Kleinrok Z; Markiewicz M
    Pol Tyg Lek; 1980 Jul; 35(30):1133-6. PubMed ID: 6904036
    [No Abstract]   [Full Text] [Related]  

  • 3. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current neurohumoral and therapeutic aspects of hypertension].
    Malaia LT; Lapshina LA
    Vestn Akad Med Nauk SSSR; 1981; (9):22-32. PubMed ID: 6913349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
    Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
    Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
    [No Abstract]   [Full Text] [Related]  

  • 6. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
    Lim PO; Jung RT; MacDonald TM
    J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
    Doi SA; Abalkhail S; Al-Qudhaiby MM; Al-Humood K; Hafez MF; Al-Shoumer KA
    J Hum Hypertens; 2006 Jul; 20(7):482-9. PubMed ID: 16617310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effects of coenzyme Q10 in essential hypertension--in relation to the renin-aldosterone system].
    Hata S; Kunida H; Oyama Y
    Horumon To Rinsho; 1977 Sep; 25(9):1019-23. PubMed ID: 923110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma kininogen and prekallikrein activity in hypertensive patients depending on the type and stage of hypertension].
    Kolber-Postepska B
    Pol Tyg Lek; 1982 Apr; 37(4-5):129-32. PubMed ID: 6921806
    [No Abstract]   [Full Text] [Related]  

  • 12. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and refractory hypertension: a prospective cohort study.
    Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
    Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of some changes induced in the vasoactive systems of renin and kallikrein during diuretic treatment of arterial hypertension].
    Covi G; Pedrolli E; Dalla Riva S; Danti G; Lechi C; Minuz P; Mattioli M; Lechi A
    G Clin Med; 1980 Feb; 61(2):134-47. PubMed ID: 7004976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Renin and hypertension risks.
    Harris L
    Ann Intern Med; 1974 Nov; 81(5):705. PubMed ID: 4420049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasopressin and renin-aldosterone system in patients with arterial hypertension].
    Kasenova SL
    Klin Med (Mosk); 2002; 80(12):31-4. PubMed ID: 12638408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.
    Park S; Kim JB; Shim CY; Ko YG; Choi D; Jang Y; Chung N
    J Hypertens; 2007 Jun; 25(6):1279-83. PubMed ID: 17563542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled study of antihypertensive effects of indapamide and metoprolol and their combination in patients with essential arterial hypertension].
    Novo S; Licata G; Pinto A; Davì G; Pepe S; Di Vitale P; Mannino V; Strano A
    Cardiologia; 1982; 27(8):765-88. PubMed ID: 6765445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the renin-angiotensin-aldosterone and kallikrein systems in normo- and hypertensive pregnant women].
    Melamed V; Tŭrkolev N; Kholevich B; Kurtev I
    Akush Ginekol (Sofiia); 1984; 23(2):113-7. PubMed ID: 6377942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.